---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-037858"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2024-09-24T23:59:59+00:00"
generated_at: "2026-05-31T02:11:03.678950+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Calidi Biotherapeutics elects Alan Stewart as director, ratifies auditor at annual meeting

## Summary
- Quorum of 57.57% (4,641,839 shares) present at Sep 20, 2024 annual meeting.
- Alan Stewart elected Class I director with 2,055,631 votes for; 2,586,208 abstentions, no against.
- George Ng did not stand for re-election; Board reduced from 6 to 5 members, no vacancy.
- Ratification of Marcum LLP as auditor passed with 4,547,883 for, 36,790 against, 57,166 abstain.

## SEC filing metadata
- accession: 0001493152-24-037858
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2024-09-24T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315224037858/0001493152-24-037858-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315224037858/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-037858
- JSON: https://secwatch.observer/filing/0001493152-24-037858.json
- Plain text: https://secwatch.observer/filing/0001493152-24-037858.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.